User menu

Accès à distance ? S'identifier sur le proxy UCLouvain | Saint-Louis

Search

Displaying 19 results.
    • Journal article
    ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): Final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial
    Mounier, N. Brice, P. Bologna, S. Briere, J. Gaillard, I. Heczko, M. Gabarre, J. Casasnovas, O. Jaubert, J. Colin, P. Delmer, A. Devidas, A. Bachy, E. Nicolas-Virelizier, E. Aoudjhane, A. Humbrecht, C. André, M.[UCL] Carde, P. Divine, M. Fenaux, P. Coiffier, B. Reman, O. Aoudjhane, M. Blaise, A.M. Bordessoule, D. Bosly, André[UCL] Morschhauser, F. Caillot, D. Gonzalez, H. Lederlin, P. Bouabdallah, R. van Hoof, A. Boulat, O. Bauduer, F. Tournilhac, O. Decaudin, D. Sebban, C. Janvier, M. Kentos, A. Voillat, L. Fabbro, M. Eisenmann, J.C. Martin, C. Christian, B. Ferrant, Augustin[UCL] Salanoubat, C. Varet, B. Bouabdallah, K. de Prijck, B. Levaltier, X. Castaigne, S. Audhuy, B. Frenkiel, N. Rose, C. Fitoussi, O. Orfeuvre, H. Pignon, J.M. (2014) Annals of Oncology — Vol. 25, no.8, p. 1622-1628 (2014)
    • Journal article
    Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II lymphoma study Association trial
    Mounier, N. El Gnaoui, T. Tilly, H. Canioni, D. Sebban, C. Casasnovas, R.-O. Delarue, R. Sonet, Anne[UCL] Beaussart, P. Petrella, T. Castaigne, S. Bologna, S. Salles, G. Rahmouni, A. Gaulard, P. Haioun, C. (2013) Haematologica : journal of hematology — Vol. 98, no.11, p. 1726-1731 (2013)
    • Journal article
    Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): A randomised phase 3 trial
    Delarue, R. Tilly, H. Mounier, N. Petrella, T. Salles, G. Thieblemont, C. Bologna, S. Ghesquières, H. Hacini, M. Fruchart, C. Ysebaert, L. Fermé, C. Casasnovas, O. Van Hoof, A. Thyss, A. Delmer, A. Fitoussi, O. Molina, T.J. Haioun, C. Bosly, André[UCL] (2013) The Lancet Oncology — Vol. 14, no.6, p. 525-533 (2013)
    • Speech
    Rituximab plus CHOP (R-CHOP) in the treatment of elderly patients with diffuse large B-cell lymphoma. An update of the GELA study.
    Coiffier, B. Ferme, C Hermine, O. Haioun, C. Baumelou, E Solal-Celigny, P. Delmer, A. Sebban, C. Mounier, N. Tertian, G Van Hoof, A. Bosly, André[UCL] (2001) —
    • Journal article
    Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87) - A GELA study
    Cazals-Hatem, D André, Marc Mounier, N. Copin, MC Divine, M. Berger, F. Bosly, André[UCL] Kerneis, Y Briere, J Quesnel, B Diebold, J Gaulard, P. (2001) American Journal of Surgical Pathology — Vol. 25, no. 3, p. 297-306 (2001)
    • Speech
    Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma (NHL) with the ACVBP regimen. A GELA (Groupe d'Etude des Lymphomes de l'Adulte) cohort study on 2849 patients.
    André, Marc Mounier, N. Leleu, X Sonet, Anne Brice, P. Tilly, H. Coiffier, B. Bosly, André[UCL] Morel, Priscilla[UCL] Haioun, C. Gaulard, P. Gisselbrecht, C. (2001) —
    • Journal article
    Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients
    André, Marc Mounier, N. Leleu, X Sonet, Anne Brice, P. Henry-Amar, M Tilly, H. Coiffier, B. Bosly, André[UCL] Morel, Priscilla[UCL] Haioun, C. Gaulard, P. Reyes, F. Gisselbrecht, C. (2004) Blood — Vol. 103, no. 4, p. 1222-1228 (2004)
    • Journal article
    T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: A matched-control analysis
    Bouabdallah, R. Mounier, N. Guettier, C. Molina, T Ribrag, V. Thieblemont, C Sonet, Anne Delmer, A. Belhadj, K Gaulard, P. Gisselbrecht, C. Xerri, L (2003) Journal of Clinical Oncology — Vol. 21, no. 7, p. 1271-1277 (2003)
    • Journal article
    Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of Hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: Results of the GRAAL1
    Coiffier, B. Mounier, N. Bologna, S. Ferme, C Tilly, H. Sonet, Anne Christian, B. Casasnovas, O. Jourdan, E Belhadj, K Herbrecht, R. (2003) Journal of Clinical Oncology — Vol. 21, no. 23, p. 4402-4406 (2003)
    • Journal article
    Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: The LNH87-1 study
    Tilly, H. Mounier, N. Lederlin, P. Briere, J Dupriez, B. Sebban, C. Bosly, André[UCL] Biron, P. Nouvel, C. Herbrecht, R. Bordessoule, D. Coiffier, B. (2000) Journal of Clinical Oncology — Vol. 18, no. 6, p. 1309-1315 (2000)
    • Journal article
    Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
    Ferme, C Mounier, N. Casasnovas, O. Brice, P. Divine, M. Sonet, Anne Bouafia, F Bastard-Stamatoullas, A Bordessoule, D. Voillat, L Reman, O. Blanc, M. Gisselbrecht, C. (2006) Blood — Vol. 107, no. 12, p. 4636-4642 (2006)
    • Speech
    90yttrium Ibritumomab Tiuxetan (zevalin) Combined With Beam (z-beam) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed Or Refractory Follicular Lymphoma. a Gela Phase Ii Prospective Study
    Gisselbrecht, C. Decaudin, D. Mounier, N. Tilly, H. Ribrag, V. Sebban, C. Milpied, N. Morschhauser, F. Coiffier, B. Le Gouill, S. Lederlin, P. Delarue, R. Laurent, Gabrielle[UCL] Bosly, André[UCL] (2009) 14th Annual Meeting of the European-Hematology-Association — Berlin(Germany)
    • Speech
    Ancestim (stem cell factor, SCF) in combination with filgrastim can mobilize sufficient peripheral blood progenitor cells (PBPC) to support high-dose salvage chemotherapy and late intensification in relapsing and refractory aggressive non-Hodgkin's lymphoma. A GELA study.
    Haioun, C. Ferrant, Augustin[UCL] Van Hoof, A. Thieblemont, C Hulin, C. Mounier, N. Tilly, H. Sebban, C. Allain, A Lepage, E. Osselaer, Jean-Claude[UCL] Beaujean, F Vannerom, H Cailliot, C Bosly, André[UCL] (2003) 45th Annual Meeting of the American-Society-of-Hematology — SAN DIEGO (California)
    • Speech
    R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by autologous stem cell transplantation: CORAL study
    Gisselbrecht, C. Glass, B. Mounier, N. Gill, D. Linch, D. Trneny, Marek Bosly, André[UCL] Shpilberg, O. Ketterer, N. Moskowitz, C. Schmitz, N. (2009) 45th Annual Meeting of the American-Society-of-Clinical-Oncology — Orlando(Fl)
    • Journal article
    Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas
    Brice, P. Cazals, D Mounier, N. Verola, O Neidhart-Berard, AM Remenieras, L Deconinck, E Doyen, Chantal Hamelsand, J Molina, T Moulonguet, I Gisselbrecht, C. (1998) Leukemia — Vol. 12, no. 2, p. 213-219 (1998)
    • Journal article
    A multivariate analysis of the survival of patients with aggressive lymphoma - Variations in the predictive value of prognostic factors during the course of the disease
    Mounier, N. Morel, Priscilla[UCL] Haioun, C. Coiffier, B. Tilly, H. Chatelain, Christian Lederlin, P. Thyss, A Herbrecht, R. Gisselbrecht, C. Lepage, E. (1998) Cancer — Vol. 82, no. 10, p. 1952-1962 (1998)
    • Journal article
    Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
    Mounier, N. Briere, J Gisselbrecht, C. Emile, JF Lederlin, P. Sebban, C. Berger, F. Bosly, André[UCL] Morel, Priscilla[UCL] Tilly, H. Bouabdallah, R. Reyes, F. Gaulard, P. Coiffier, B. (2003) Blood — Vol. 101, no. 11, p. 4279-4284 (2003)
    • Speech
    Final results of the efficacy and safety of rasburicase (recombinant urate oxydase) for the prevention and treatment of hyperuricemia in patients with aggressive lymphoma (GRAAL 1 study).
    Coiffier, B. Mounier, N. Bologna, S. Ferme, C Herbrecht, R. Tilly, H. Sonet, Anne Christian, B. Casasnovas, O. Jourdan, E Belhadj, K (2002) 44th Annual Meeting of the American-Society-of-Hematology — PHILADELPHIA(Pennsylvania)
    • Speech
    Safety of prophylactic use of darbepoetin alfa in patients with diffuse large B-Cell lymphoma (DLBCL) treated with R-CHOP 14 or RCHOP21: Preliminary results of the LNH03-6B randomized GELA study.
    Delarue, R. Mounier, N. Haioun, C. Coiffier, B. Gisselbrecht, C. Ghesquieres, H. Lederlin, P. Blanc, M. Recher, C. Hermine, O. Reyes, F. Tilly, H. Bosly, André[UCL] (2006) 48th Annual Meeting of the American-Society-of-Hematology — Orlando(Fl)